Total Funding
81
75
Total FundingPost-IPO Debt raised
Growth Score 81 in past quarter
-12 pts
Heat Score 75 in past quarter
16 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
30908
Maravai is a life sciences company providing critical products to enable the development of drug therapies, diagnostics, novel vaccines.
- Brett Telford: Senior Director, Assistant ControllerPast Role: GAIN Credit, Corporate Controller
- Carl W Hull: Executive ChairmanPast Role: Maravai Life Sciences, Partner, Co-Founder & CEO
About the Company
Maravai LifeSciences was formed in March 2014 as a partnership among Carl Hull and Eric Tardif -- proven leaders in the life sciences industry -- and GTCR, a leading private equity firm. Maravai’s mission is to build a transformative life sciences products company by acquiring outstanding businesses and accelerating their growth. They do this
through direct cash investments in their existing operations, by acquiring complementary businesses or product lines and by contributing our proven operating expertise.

